Novel therapeutic uses for porphyrins and phthalocyanines in the transmissible spongiform encephalopathies: Commentary

Current Opinion in Microbiology

Volumn 2, Issue 5, 1999, Pages 563-566

  Priola, Suzette A ^a   Caughey, Byron ^a   Caughey, Winslow S ^a  

^a Lab of Persistent Viral Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4' IODOESORUBICIN; AMPHOTERICIN B; CHONDROITIN SULFATE; CONGO RED; DEUTEROPORPHYRIN IX; DEXTRAN; DEXTRAN SULFATE; PENTOSAN POLYSULFATE; PHTHALOCYANINE DERIVATIVE; PORPHYRIN DERIVATIVE;

BLOOD BRAIN BARRIER; CONFORMATIONAL TRANSITION; DRUG PENETRATION; DRUG SPECIFICITY; DRUG STRUCTURE; DRUG TARGETING; NOTE; PRION DISEASE;

EID: 0032829347     PISSN: 13695274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1369-5274(99)00020-X     Document Type: Note

References (25)

1. Pocchiari M Prions and related neurological diseases. Mol Aspects Med. 15:1994;195-291.
2. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, Poser S, Pocchiari M, Hofman A, Smith PG A new variant of Creutzfeldt-Jakob disease in the UK. Lancet. 347:1996;921-925.
3. Collinge J, Sidle KCL, Meads J, Ironside J, Hill AF Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature. 383:1996;685-690.
4. Raymond GJ, Hope J, Kocisko DA, Priola SA, Raymond LD, Bossers A, Ironside J, Will RG, Chen SG, Petersen RBet al. Molecular assessment of the transmissibilities of BSE and scrapie to humans. Nature. 388:1997;285-288.
5. Bruce ME, Will RG, Ironside JW, McConnell I, Drummond D, Suttie A, McCardle L, Chree A, Hope J, Birkett Cet al. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature. 389:1997;498-501.
6. Will RG, Cousens SN, Farrington CP, Smith PG, Knight RSG, Ironside JW Deaths from variant Creutzfeldt-Jakob disease. Lancet. 353:1999;979.
7. Brown P A therapeutic panorama of the spongiform encephalopathies. Antiviral Chemistry & Chemotherapy. 1:1990;75-83.
8. Adjou KT, Deslys J-P, Demaimay R, Seman M, Dormont D Prospects for the pharmacological treatment of human prion diseases. CNS Drugs. 10:1998;83-89.
9. Prusiner SB Novel proteinaceous infectious particles cause scrapie. Science. 216:1982;136-144.
10. Alper T, Cramp WA, Haig DA, Clarke MC Does the agent of scrapie replicate without nucleic acid? Nature. 214:1967;764-766.
11. Race RE, Caughey B, Graham K, Ernst D, Chesebro B Analyses of frequency of infection, specific infectivity, and prion protein biosynthesis in scrapie-infected neuroblastoma cell clones. J Virol. 62:1988;2845-2849.
12. Caughey B, Raymond GJ Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells. J Virol. 67:1993;643-650.
13. Kocisko DA, Come JH, Priola SA, Chesebro B, Raymond GJ, Lansbury PT, Caughey B Cell-free formation of protease-resistant prion protein. Nature. 370:1994;471-474.
14. Caughey WS, Raymond LD, Horiuchi M, Caughey B Inhibition of protease-resistant prion protein formation by porphyrins and phthalocyanines. Proc Natl Acad Sci USA. 95:1998;12117-12122.
15. Caughey B, Race RE Potent inhibition of scrapie-associated PrP accumulation by Congo red. J Neurochem. 59:1992;768-771.
16. Caughey B, Ernst D, Race RE Congo red inhibition of scrapie agent replication. J Virol. 67:1993;6270-6272.
17. Demaimay R, Harper J, Gordon H, Weaver D, Chesebro B, Caughey B Structural aspects of Congo red as an inhibitor of protease-resistant prion protein formation. J Neurochem. 71:1998;2534-2541.
18. Bonnett R Photosensitizers of the porphyrin and phthalocyanine series for photodynamic therapy. Chem Soc Rev. 24:1995;19-33.
19. Dolphin D The Porphyrins. 1978;Academic Press, New York.
20. Ladogana A, Casaccia P, Ingrosso L, Cibati M, Salvatore M, Xi YG, Masullo C, Pocchiari M Sulphate polyanions prolong the incubation period of scrapie-infected hamsters. J Gen Virol. 73:1992;661-665.
21. Ehlers B, Diringer H Dextran sulphate 500 delays and prevents mouse scrapie by impairment of agent replication in spleen. J Gen Virol. 65:1984;1325-1330.
22. Tagliavini F, McArthur RA, Canciani B, Giaccone G, Porro M, Bugiani M, Lievens PM-J, Bugiani O, Peri E, Dall'Ara Pet al. Effectiveness of anthracycline against experimental prion disease in syrian hamsters. Science. 276:1998;1119-1122.
23. Pocchiari M, Schmittinger S, Masullo C Amphotericin B delays the incubation period of scrapie in intracerebrally inoculated hamsters. J Gen Virol. 68:1987;219-223.
24. Kimberlin RH, Walker CA Suppression of scrapie infection in mice by heteropolyanion 23, dextran sulfate, and some other polyanions. Antimicrob Agents Chemother. 30:1986;409-413.
25. Priola SA, Caughey B Inhibition of scrapie-associated PrP accumulation: Probing the role of glycosaminoglycans in amyloidogenesis. Mol Neurobiol. 8:1994;113-120.